Evaluating the Impact of Dienogest on Quality of Life in Turkish Patients with Endometriosis: A Clinical Study

In: Acıbadem Üniversitesi Sağlık Bilimleri Dergisi · 2025 · vol. 16(4) , pp. 534–539 · doi:10.31067/acusaglik.1668799 · W4414187977
article OA: diamond CC0
AI-generated summary by claude@2026-06, 2026-06-08

Dienogest treatment significantly improved overall quality of life and specific domains including pain, self-image, and emotional well-being in Turkish patients with endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Purpose This study aimed to evaluate the effectiveness of dienogest in alleviating the negative effects associated with endometriosis in Turkish patients. The impact of the treatment on health-related quality of life (HRQoL) was assessed using the validated Turkish version of the Endometriosis Health Profile-30 (EHP-30) questionnaire. Methods A total of 119 patients with a confirmed diagnosis of endometrioma characterized by a unilocular cyst with homogeneous ground-glass echogenicity were included in this study, conducted at a tertiary care center. All participants were prescribed or already have been prescribed a continuous regimen of 2 mg/day dienogest for symptom control. Each patient completed the core section of the EHP-30 questionnaire twice: before treatment initiation and after a defined treatment period. Results A significant improvement was observed in total EHP-30 scores (from 96.92 to 52.03, p < .001). Notable improvements were also found in the pain (p < .001), self-image (p < .001), and emotional well-being (p < .001) subdomains. Changes in EHP-30 scores were not found to be significantly correlated with treatment duration, reduction in endometrioma size, or changes in CA125 levels. Conclusion Dienogest significantly improves quality of life even with short-term use and stands out as an effective treatment option for endometriosis.

My notes (saved in your browser only)

Outcome instruments

EHP-30

Condition tags

endometriosisendometrioma

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (15)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK